Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.
Prince Court Medical Centre provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 2007, the MSQH accredited hospital is based in Kuala Lumpur, Malaysia, with 277 beds and services for domestic and international patients.
The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.
Acibadem International Hospital provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 1989, the JCI accredited hospital is based in Istanbul, Turkey, with 112 beds and services for domestic and international patients.
The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.
At Asan Medical Centre, patients can access comprehensive Cholangiocarcinoma Treatment supported by advanced diagnostic, surgical, and oncology facilities. Established in 1989, the ISO accredited hospital is located in Seoul, South Korea, and has 2700 beds.
Bile duct cancer treatment is personalised according to the tumour's location, stage, and overall health of the patient. Potentially operable tumours may be treated with surgery, while patients with advanced disease may receive systemic therapies such as chemotherapy, targeted medicines, or immunotherapy. Biliary drainage or stenting may also be used to relieve obstruction when required.
Bangkok Hospital offers specialised Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern surgical and medical oncology technologies and established treatment protocols. Established in 1972, the JCI accredited hospital is situated in Bangkok, Thailand, with 580 beds, serving local and international patients.
Treatment may include surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, or biliary drainage procedures, depending on the cancer's location and stage. Molecular testing may identify specific alterations that could make targeted treatment appropriate. Before therapy, specialists conduct comprehensive imaging, pathology, staging, and liver-function assessments to develop an individualised treatment plan.
Mount Elizabeth Hospital provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 1979, the JCI accredited hospital is based in Singapore, Singapore, with 345 beds and services for domestic and international patients.
The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.
With advanced hepatobiliary oncology infrastructure, Kings College Hospital Dubai offers Cholangiocarcinoma Treatment for patients requiring specialised care for bile duct cancer. Established in 2019, the JCI accredited hospital is located in Dubai, United Arab Emirates, and has 100 beds.
For selected patients with resectable disease, surgery may involve removal of the affected bile duct, part of the liver, or other nearby tissues, depending on tumour location. Advanced disease may require systemic treatment or palliative procedures such as biliary stenting. A multidisciplinary team evaluates imaging, pathology, tumour stage, and overall health before recommending treatment.
At Parkway Pantai, patients can access comprehensive Cholangiocarcinoma Treatment supported by advanced diagnostic, surgical, and oncology facilities. Established in 1974, the JCI, MSQH accredited hospital is located in Kuala Lumpur, Malaysia, and has 499 beds.
Bile duct cancer treatment is personalised according to the tumour's location, stage, and overall health of the patient. Potentially operable tumours may be treated with surgery, while patients with advanced disease may receive systemic therapies such as chemotherapy, targeted medicines, or immunotherapy. Biliary drainage or stenting may also be used to relieve obstruction when required.
Vejthani Hospital provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 1994, the JCI accredited hospital is based in Bangkok, Thailand, with 263 beds and services for domestic and international patients.
The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.
Memorial Ankara Hospital offers specialised Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern surgical and medical oncology technologies and established treatment protocols. Established in 2014, the JCI accredited hospital is situated in Ankara, Turkey, with 230 beds, serving local and international patients.
Treatment may include surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, or biliary drainage procedures, depending on the cancer's location and stage. Molecular testing may identify specific alterations that could make targeted treatment appropriate. Before therapy, specialists conduct comprehensive imaging, pathology, staging, and liver-function assessments to develop an individualised treatment plan.
Artemis Health Institute provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 2007, the JCI, NABH accredited hospital is based in Gurgaon, India, with 750 beds and services for domestic and international patients.
The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.
With advanced hepatobiliary oncology infrastructure, Gleneagles Hospital offers Cholangiocarcinoma Treatment for patients requiring specialised care for bile duct cancer. Established in 1959, the JCI accredited hospital is located in Singapore, Singapore, and has 258 beds.
For selected patients with resectable disease, surgery may involve removal of the affected bile duct, part of the liver, or other nearby tissues, depending on tumour location. Advanced disease may require systemic treatment or palliative procedures such as biliary stenting. A multidisciplinary team evaluates imaging, pathology, tumour stage, and overall health before recommending treatment.
International St. Mary's Hospital provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 2014, the JCI accredited hospital is based in Seoul, South Korea, with 808 beds and services for domestic and international patients.
The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.
Sunway Medical Centre offers specialised Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern surgical and medical oncology technologies and established treatment protocols. Established in 1999, the ACHS accredited hospital is situated in Kuala Lumpur, Malaysia, with 724 beds, serving local and international patients.
Treatment may include surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, or biliary drainage procedures, depending on the cancer's location and stage. Molecular testing may identify specific alterations that could make targeted treatment appropriate. Before therapy, specialists conduct comprehensive imaging, pathology, staging, and liver-function assessments to develop an individualised treatment plan.
At Bangpakok 9 International Hospital, patients can access comprehensive Cholangiocarcinoma Treatment supported by advanced diagnostic, surgical, and oncology facilities. Established in 2003, the JCI, GHA accredited hospital is located in Bangkok, Thailand, and has 300 beds.
Bile duct cancer treatment is personalised according to the tumour's location, stage, and overall health of the patient. Potentially operable tumours may be treated with surgery, while patients with advanced disease may receive systemic therapies such as chemotherapy, targeted medicines, or immunotherapy. Biliary drainage or stenting may also be used to relieve obstruction when required.
Dubai, United Arab Emirates
Aster DM Healthcare provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 1987, the JCI, NABH, NABL accredited hospital is based in Dubai, United Arab Emirates, with 114 beds and services for domestic and international patients.
The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.
